Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Extracellular CD30 and ADAM10/17 Regulate Brentuximab Vedotin-Induced Cell Death in an Adult T-Cell Leukemia Cell Line

Keisuke Sato, Tomohiro Kozako, Akira Nakano, Kentaro Ogata, Hidetoshi Kamimura, Hidenori Sasaki, Yasushi Takamatsu, Shigeki Takemoto, Shin-Ichiro Honda

Blood (2023) 142 (Supplement 1): 5803.

https://doi.org/10.1182/blood-2023-173221

Published: 2023

Journal Articles

Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced-Intensity Conditioning Regimen with Fludarabine and Busulfan from HLA-Matched Related Donor for Elderly Adult T-Cell Leukemia/Lymphoma: Results of Multicenter Phase II Study (ATL-NST-3)

Ryuji Tanosaki, MD PhD, Ilseung Choi, MD, Mototsugu Shimokawa, PhD, Atae Utsunomiya, MD PhD, Masahito Tokunaga, MD, Nobuaki Nakano, MD, Takahiro Fukuda, MD, Hirohisa Nakamae, Shigeki Takemoto, MD PhD, Shigeru Kusumoto, MD PhD, Takeaki Tomoyose, Eisaburo Sueoka, MD PhD, Motoaki Shiratsuchi, Youko Suehiro, MD, Takeharu Yamanaka, PhD, Jun Okamura, MD, Naokuni Uike

Blood (2014) 124 (21): 2580.

https://doi.org/10.1182/blood.V124.21.2580.2580

Published: 2014

Journal Articles

A Prospective Feasibility Trial of Unrelated Bone Marrow Transplantation with Reduced Intensity Conditioning Regimen for Elderly Patients with Adult T-Cell Leukemia/Lymphoma (ATL),

Tetsuya Eto, MD, Ilseung Choi, MD, Ryuji Tanosaki, MD, Yoshifusa Takatsuka, MD, Atae Utsunomiya, MD, Shigeki Takemoto, MD, PhD, Jun Taguchi, MD, Takuya Fukushima, MD, Koji Kato, MD, PhD, Takanori Teshima, MD, PhD, Yoko Suehiro, MD, Takeharu Yamanaka, PhD, Jun Okamura, MD, Naokuni Uike, MD, PhD

Blood (2011) 118 (21): 4163.

https://doi.org/10.1182/blood.V118.21.4163.4163

Published: 2011

Journal Articles

Multicenter Phase II Study of KW-0761, a Defucosylated Anti-CCR4 Antibody, In Relapsed Patients with Adult T-Cell Leukemia-Lymphoma (ATL)

Blood (2010) 116 (21): 285.

https://doi.org/10.1182/blood.V116.21.285.285

Published: 2010

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.

Shigeki Takemoto, MD, Michihiro Hidaka, MD, Shoichi Nagakura, MD, Tatsunori Sakai, MD, Takahiro Matsui, MD, Toshiro Kawakita, MD, Yoshiko Inoue, MD, Atsuko Tsukamoto, MD, Tetsuyuki Kiyokawa, MD, Fumio Kawano, MD

Blood (2007) 110 (11): 5037.

https://doi.org/10.1182/blood.V110.11.5037.5037

Published: 2007

Journal Articles

Minimal Residual Disease (MRD) in Adult T-Cell Leukemia/Lymphoma (ATLL) Evaluated by HTLV-1 Proviral Load and Soluble IL-2 Receptor Level in Peripheral Blood.

Kunihiro Tsukasaki, Shigeki Takemoto, Hirokuni Taguchi, Masato Masuda, Syuichi Ikeda, Shinichiro Yoshida, Hitoshi Suzushima, Naokuni Uike, Yoshio Saburi, Fumio Kawano, Masaomi Yamamura, Eizaburo Sueoka, Masaharu Miyahara, Masao Tomonaga

Blood (2005) 106 (11): 2821.

https://doi.org/10.1182/blood.V106.11.2821.2821

Published: 2005

Journal Articles

HV MNE , a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits

Maria G. Ferrari, Emilia D. Rivadeneira, Ruth Jarrett, Liljana Stevceva, Shigeki Takemoto, Phil Markham, Genoveffa Franchini

Blood (2001) 98 (7): 2193–2199.

https://doi.org/10.1182/blood.V98.7.2193

Published: 2001

Journal Articles

Bcl-X L is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples

Christophe Nicot, Renaud Mahieux, Shigeki Takemoto, Genoveffa Franchini

Blood (2000) 96 (1): 275–281.

https://doi.org/10.1182/blood.V96.1.275

Published: 2000

Journal Articles

p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14 ARF –MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells

Shigeki Takemoto, Raffaella Trovato, Anna Cereseto, Christophe Nicot, Tatiana Kislyakova, Luca Casareto, Thomas Waldmann, Giuseppe Torelli, Genoveffa Franchini

Blood (2000) 95 (12): 3939–3944.

https://doi.org/10.1182/blood.V95.12.3939

Published: 2000

NARROW

Extracellular CD30 and ADAM10/17 Regulate Brentuximab Vedotin-Induced Cell Death in an Adult T-Cell Leukemia Cell Line

Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced-Intensity Conditioning Regimen with Fludarabine and Busulfan from HLA-Matched Related Donor for Elderly Adult T-Cell Leukemia/Lymphoma: Results of Multicenter Phase II Study (ATL-NST-3)

A Prospective Feasibility Trial of Unrelated Bone Marrow Transplantation with Reduced Intensity Conditioning Regimen for Elderly Patients with Adult T-Cell Leukemia/Lymphoma (ATL),

Multicenter Phase II Study of KW-0761, a Defucosylated Anti-CCR4 Antibody, In Relapsed Patients with Adult T-Cell Leukemia-Lymphoma (ATL)

Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.

Minimal Residual Disease (MRD) in Adult T-Cell Leukemia/Lymphoma (ATLL) Evaluated by HTLV-1 Proviral Load and Soluble IL-2 Receptor Level in Peripheral Blood.

HV MNE , a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits

Bcl-X L is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples

p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14 ARF –MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only